Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital autosomal recessive sideroblastic anemia (ARSA) is a non-syndromic, microcytic/hypochromic sideroblastic anemia, present from early infancy and characterized by severe microcytic anemia, which is not pyridoxine responsive, and increased serum ferritin.
10 clinical trials registered, 6 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 5 PHASE4, 2 PHASE3, 1 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06884280](https://clinicaltrials.gov/study/NCT06884280) |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
PHASE3 |
Hull University Teaching Hospitals NHS Trust |
RECRUITING |
[NCT07308769](https://clinicaltrials.gov/study/NCT07308769) | Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women | PHASE4 | Pharmanutra S.p.a. | RECRUITING |
[NCT06637137](https://clinicaltrials.gov/study/NCT06637137) | Patient Blood Management in Patients Scheduled for Cardiac Surgery | — | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | RECRUITING |
[NCT05929729](https://clinicaltrials.gov/study/NCT05929729) | Iron Deficiency Anemia (IDA) and the Brain | PHASE4 | Children's Hospital Los Angeles | RECRUITING |
[NCT05407987](https://clinicaltrials.gov/study/NCT05407987) | Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) | PHASE3 | AHS Cancer Control Alberta | RECRUITING |
27 publications have been identified in PubMed for autosomal recessive sideroblastic anemia. Research spans Case Report / Case Series (48%), Basic Science / Preclinical (26%), and Review / Meta-Analysis (19%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 48% |
Laboratory research | 7 | 26% |
Research summaries | 5 | 19% |
Other research | 1 | 4% |
Disease patterns and progression | 1 | 4% |
Zhao D (2026). [PMID: 41903915](https://pubmed.ncbi.nlm.nih.gov/41903915/). *Gene*. [Review / Meta-Analysis]
Ciurej A (2026). [PMID: 41925069](https://pubmed.ncbi.nlm.nih.gov/41925069/). *Pediatr Blood Cancer*. [Case Report / Case Series]
Chen ZX (2026). [PMID: 41961321](https://pubmed.ncbi.nlm.nih.gov/41961321/). *Ann Hematol*. [Case Report / Case Series]
Hasani E (2026). [PMID: 41714435](https://pubmed.ncbi.nlm.nih.gov/41714435/). *Ann Hematol*. [Basic Science / Preclinical]
Jové-Solavera D (2025). [PMID: 40195342](https://pubmed.ncbi.nlm.nih.gov/40195342/). *Sci Rep*. [Case Report / Case Series]
Ammar M (2025). [PMID: 39961824](https://pubmed.ncbi.nlm.nih.gov/39961824/). *Ann Hematol*. [Case Report / Case Series]
Fujiwara T (2025). [PMID: 40769913](https://pubmed.ncbi.nlm.nih.gov/40769913/). *Rinsho Ketsueki*. [Review / Meta-Analysis]
Ng K (2025). [PMID: 40425209](https://pubmed.ncbi.nlm.nih.gov/40425209/). *BMJ Case Rep*. [Case Report / Case Series]
Gradim M (2025). [PMID: 40185132](https://pubmed.ncbi.nlm.nih.gov/40185132/). *Acta Med Port*. [Other]
Novoa-Jáuregui S (2025). [PMID: 40335618](https://pubmed.ncbi.nlm.nih.gov/40335618/). *Leukemia*. [Epidemiology / Natural History]